Document is current
Any future updates will be listed below
-
Authors
Kario, Kazuomi
Nishiyama, Akira
Shibata, Shigeru
Mogi, Masaki
Arima, Hisatomi
Kishi, Takuya
Ishida, Mari
Furuhashi, Masato
Ichihara, Atsuhiro
Katsuya, Tomohiro
Miura, Katsuyuki
Miura, Shin-ichiro
Ohishi, Mitsuru
Shibata, Hirotaka
Shimosawa, Tatsuo
Sugawara, Akira
Tamura, Kouichi
Toyoda, Kazunori
Yamamoto, Koichi
Hoshide, Satoshi
Nakagawa, Naoki
Tomita, Hirofumi
Tanaka, Atsushi
Hozawa, Atsushi
Hatta, Tsuguru
Nomura, Akihiro
Kabayama, Mai
Rakugi, Hiromi
Ohya, Yusuke
Node, Koichi
,
Tomita, Hirofumi
Shimosawa, Tatsuo
Kai, Hisashi
Arakawa, Kimika
Kawarazaki, Wakako
Okamura, Tomonori
Takemi, Yukari
Kaneko, Hidehiro
Shinohara, Keisuke
Hirawa, Nobuhito
Sakima, Atsushi
Ohkubo, Takayoshi
Asayama, Kei
Tomitani, Naoko
- License Information
-
More Information
Article History
Received: 25 July 2025
Accepted: 28 July 2025
First Online: 26 August 2025
Compliance with ethical standards
:
: Kazuomi Kario has received research grants from A&D Co., Ltd., Omron Healthcare Co., Ltd., Fukuda Denshi Co., Ltd., and CureApp, Inc., and honoraria from Novartis Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., Viatris Inc., and CureApp, Inc. Tatsuo Shimosawa has received a research grant from SFM Co., Ltd., and lecturer fees from Novartis Pharma Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Nippon Boehringer Ingelheim Co., Ltd. Akihiro Nomura received joint research grants from CureApp, Inc. and Bionics Co., Ltd., and consulting fees from Sky Labs, Inc. Hiromi Rakugi has received research expenses from Novartis Pharma Co., Ltd., and lecturer fees from Otsuka Pharmaceutical Co., Ltd., Daiichi Sankyo Co., Ltd., and Novartis Pharma Co., Ltd. The other authors declare they have no competing interests.
Free to read: This content has been made available to all.
